Trial
NCT05057689
Safety & Efficacy of Intranasal Dexmedetomidine, Fentanyl & Midazolam in the Pediatric Emergency Room
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Nationwide Children's Hospital
Collaborators
—
Condition
Acute Stress Disorder
Intervention
Intranasal Dexmedetomidine (4 mcg/kg)
Why stopped
Unable to obtain funding to initiate/complete study
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-09-10